We are so excited to introduce Sermorelin injections to our Wellness Program. Sermorelin is a bio-identical hormone that has been engineered to stimulate the secretion of growth hormone releasing hormones. As we age our body produces less and less of our own vital hormones especially growth hormone. Studies show that Sermorelin can restore this incredibly important hormone to youthful levels and melt fat away along with producing a myriad of other benefits such as:
- Increased collagen production
- Increased energy
- Improved quality of sleep
- Increase in immune function
- Expedited healing & recovery
- Enhanced sexual performance
- Reduction & disappearance of wrinkles & cellulite
- …to name just a few!
Sermorelin Injections FAQ
Question: How is Sermorelin Packaged?
Answer: Sermorelin will come in a sterile multi-dosed, injectable vial. Each vial contains a powder disc, which contains the Sermorelin Acetate and GHRP-2. The vial is vacuum-sealed by the pharmacy for your protection and for the preservation of the hormone peptide. We will re-constitute the powder with a bacteriostatic water for you. Bacteriostatic water mixed with the Sermorelin/GHRP-2 results in the solution utilized for injection. Administration and storage instruction will be provided with your prescription.
Question: How Do I Take Sermorelin?
Answer: Sermorelin is injected into the body fat, subcutaneously, using a very small needle, similar to what a diabetic may use to inject insulin. Injections are initially prescribed for every day and are decreased in frequency over time.
Question: When Do I Take Sermorelin?
Answer: The endocrine system is most active at night. It is most effective to administer your Sermorelin just prior to bedtime, about 15 minutes. Keep in mind, it is during REM sleep that your body is mainly releasing Growth Hormone, as it is most beneficial to the body’s recovery and repair during this time. Sermorelin also promotes sleepiness. It helps you get into deep sleep very quickly and effectively and can therefore make you tired if taken during the day.
Question: How Do You Measure Effectiveness?
Answer: Dr Summer Beattie, N.D., specializes in assisting patients to understand how they personally are affected and benefiting from their qualified programs. Due to the pulsatile nature of both endogenous HGH and IGF-1, a single blood draw is not sufficient for accurate measurement. Therefore, she will measure the effectiveness in patients through symptomology (the study of your symptoms both physical appearance, measurements and subjective reporting). Additional and more frequent blood analysis is the most accurate way to ensure effectiveness and your safety throughout your protocol. We will recommend repeated blood testing at various intervals.
Question: How Will I Know It’s Working?
Answer: Several things should be expected to form a properly administered Sermorelin program. Remember that Sermorelin is another form of GH therapy, so your list of benefits will read the same as what you’d expect from an HGH therapy. Initially, patients on Sermorlin therapy should expect:
- Improved sleep quality
- Increased energy levels
- Improved mood
After 3 – 6 months of therapy, patients start reporting:
- Increase in muscle tone and a leaner physique
- Reduction of fat in mid-section
- Lean muscle gain
- Increased immune function
- Enhanced sexual performance
- Increased cardiac output
- Improved skin elasticity
- Disappearance of wrinkles
- Reduction in appearance of cellulite
- Improved vision
- Increased memory retention
- Increased exercise performance
- Expedited wound healing
- Lower blood pressure
- Improved cholesterol levels
- Increased bone mass and rigidity
Question: WHAT ARE POSSIBLE SIDE EFFECTS?
Answer: No generalized allergic reactions to Sermorelin have been reported. The most common treatment-related adverse event (occurring in about 1 patient in 6) is local injection reaction characterized by pain, swelling or redness. Of 350 patients exposed to Sermorelin in clinical trials, 3 discontinued therapy due to injection reactions. Other treatment-related adverse events had individual occurrence rates of less than 1% and include: headache, flushing, dizziness, hyperactivity and somnolence. When administering intravenously for diagnostic use, the following adverse reactions have been noted: flushing face, injection site pain, redness and/or swelling, nausea, headaches, vomiting, and tightness in chest.